The carotid arteries, critical conduits supplying blood to the brain, are frequent sites where atherosclerotic plaques develop. These plaques, characterized by buildup of lipids, inflammatory cells, and fibrous tissue, are notoriously heterogeneous—not only among different patients, but also within different regions of the same artery. Traditional histological techniques lack the resolution to fully capture this cellular diversity and its spatial arrangement, obstructing efforts to identify key pathogenic processes or therapeutic targets. The new study leverages the cutting edge of molecular biology: single-cell RNA sequencing coupled with spatial transcriptomics, a technique that preserves the physical location of each individual cell’s gene expression within tissue slices.

At the heart of the investigation lies the integration of comprehensive spatial gene expression maps with morphological data derived from carotid artery samples exhibiting varying stages of atherosclerosis. Employing state-of-the-art computational frameworks, the researchers systematically reconstructed the cellular neighborhoods that define plaque architecture. This integrative approach revealed striking heterogeneity in cell populations ranging from lipid-laden macrophages to vascular smooth muscle cells, endothelial cells, and rare immune subsets. More importantly, spatial dependencies in gene expression underscored novel interactions that likely influence plaque stability and vulnerability.

One of the striking revelations of the study is how spatial transcriptomics enables the delineation of discrete cellular niches within the atherosclerotic plaque. For instance, clusters of inflammatory macrophages expressing high levels of pro-inflammatory mediators were spatially confined to regions adjacent to necrotic cores. In contrast, smooth muscle cells expressing reparative and fibrotic genes aggregated in regions contributing to fibrous caps, structures critical for preventing plaque rupture. Such spatially resolved molecular insights were previously unachievable and underscore the nuanced and dynamic interplay between cell types influencing disease progression.

Moreover, the team uncovered that gene expression signatures vary not only between distinct cell types but also within individual subpopulations depending on their spatial positioning in the artery wall. This spatial heterogeneity affects pathways governing inflammation, extracellular matrix remodeling, and lipid metabolism—factors that collectively determine whether a plaque remains stable or progresses to rupture, often leading to catastrophic clinical events. By precisely mapping these molecular gradients, the study offers a molecular atlas that can guide targeted interventions aimed at modifying plaque behavior.

Beyond static snapshots, the integration of spatial and single-cell transcriptomics also hints at temporal evolution in plaque morphology. The researchers identified transitional cellular states that likely represent stages of activation or differentiation as cells respond to microenvironmental cues in ischemic and inflamed vascular tissue. This capability to infer trajectory and plasticity from spatially anchored transcriptomes provides a powerful framework for understanding how atherosclerotic plaques evolve over time, and which cellular players might be modulated to halt or reverse disease progression.

The technical sophistication employed in this study has broad implications for the field of spatial biology. By combining advanced tissue preservation, histological staining, and in situ sequencing technologies, the team overcame significant challenges related to spatial resolution, transcriptome coverage, and data integration. Computational pipelines incorporating machine learning and network analysis were critical to decode the massive datasets generated, enabling the identification of spatial gene expression patterns that correlate with morphological features extracted from high-definition imaging. Such multidisciplinary synergy exemplifies the future of precision medicine studies.

Clinically, these insights could revolutionize diagnostic and therapeutic strategies for atherosclerosis. Current imaging modalities used to assess plaque morphology, such as ultrasound and MRI, lack molecular specificity and cannot reveal the underlying cellular states driving plaque vulnerability. The molecular and spatial signatures identified in this research could serve as biomarkers for high-risk plaques or inform the development of novel therapeutics designed to stabilize plaques by modulating specific cell populations or pathways. This precision approach could reduce stroke incidence by enabling early, targeted intervention on “at-risk” plaques before catastrophic rupture.

The study also holds promise for enabling personalized medicine approaches. With spatial transcriptomics, it becomes conceivable to generate individualized maps of plaque biology for patients undergoing carotid endarterectomy or other surgical interventions. Such detailed molecular phenotyping could facilitate tailored treatment decisions and improved prognostic accuracy, moving beyond the “one-size-fits-all” paradigm in cardiovascular care. Moreover, the technology can be extended to study other vascular beds prone to atherosclerosis, potentially broadening its impact across multiple vascular diseases.

Importantly, the work highlights that atherosclerosis is not merely a disease of lipid accumulation but a highly orchestrated multicellular process involving immune responses, tissue remodeling, and cellular crosstalk within precise spatial confines. By illuminating this complexity, the study challenges researchers to rethink therapeutic strategies that traditionally focused only on lipid lowering or broad immunosuppression. Instead, future treatments might aim to recalibrate the spatial cellular ecosystem within plaques, targeting specific pathological niches while preserving protective mechanisms.

In the context of basic science, this research is a tour de force that exemplifies the value of spatially resolved omics to dissect disease mechanisms. It sets a new standard for studies of complex tissue architecture in health and disease, inspiring analogous research in cancer, neurodegeneration, and developmental biology. The integration of single-cell resolution with spatial context is rapidly emerging as an indispensable tool in biomedical research, bridging the gap between molecular detail and physiological tissue organization.

From a technological standpoint, the authors’ methodology is a showcase of innovation. The precise preservation of tissue morphology while capturing full transcriptomes, coupled with computational integration strategies, sets a benchmark for future studies. Their pipeline can be adapted to diverse tissues and diseases, accelerating discovery and translational efforts globally. The study also underscores the importance of interdisciplinary collaboration among molecular biologists, bioinformaticians, pathologists, and clinicians, necessary to translate complex data into meaningful biological and clinical insights.

Looking forward, the insights gleaned from this study pave the way for exciting new research directions. Further exploration of how spatial cellular dynamics change in response to therapies, lifestyle factors, or co-morbidities will be invaluable. The ability to perform longitudinal spatial transcriptomic analyses on serial biopsies or animal models could uncover novel mechanisms of disease remission or exacerbation. Ultimately, integrating spatial multi-omics modalities—transcriptomics, epigenomics, proteomics—will enhance our understanding of atherosclerosis at unprecedented biological depth.

In summary, the work by Pauli, Garger, Peymani, and colleagues represents a monumental step in cardiovascular research. By decoding the spatial and molecular heterogeneity of atherosclerotic carotid arteries at single-cell resolution, they illuminate the cellular choreography underlying disease progression, opening a new frontier for diagnostics, therapeutics, and personalized medicine. As spatial transcriptomics technologies continue to evolve and scale, their impact on understanding and combating atherosclerosis and beyond will only grow more profound, heralding a new era of vascular biology.

Subject of Research: Investigation of the morphological and molecular heterogeneity of atherosclerotic carotid arteries through single-cell spatial transcriptomics integration.

Article Title: Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries.

Article References:
Pauli, J., Garger, D., Peymani, F. et al. Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries. Nat Commun (2025). https://doi.org/10.1038/s41467-025-67679-4

Image Credits: AI Generated

Atherosclerosis, characterized by the buildup of lipids, cholesterol, calcium, and cellular debris within arterial walls, is a pervasive contributor to vascular diseases worldwide. Particularly concerning are plaques forming in the carotid arteries—the principal vessels supplying oxygenated blood to the brain. Traditionally, calcification within these plaques was seen as a marker of plaque stability, presumed to fortify the lesion and reduce the likelihood of rupture. However, emerging evidence from this study complicates that narrative, revealing that plaques containing calcification are not necessarily benign, but may, in fact, be predisposed to intraplaque hemorrhage (IPH), a dangerous complication implicated in plaque destabilization.

The research team, led by Dr. Daniel Bos from Erasmus MC, University Medical Center Rotterdam, executed a longitudinal study involving 802 participants aged 45 and older, all initially free from clinical symptoms of carotid artery disease. Through high-resolution T1-weighted gradient-echo noncontrast MRI sequences, the team meticulously characterized the carotid plaque compositions twice—at baseline and six years later. This non-invasive imaging modality excelled in visualizing distinct plaque components, such as calcifications, fatty deposits, and most notably, intraplaque hemorrhages, which manifest as hyperintense signals proximate to calcified regions.

A pivotal observation from the serial MRI scans was the colocalization of pre-existing calcifications with new incidences of intraplaque hemorrhages within the same plaques. This phenomenon was particularly troubling, as IPH is recognized as one of the most significant predictors of plaque rupture and subsequent stroke. Through quantitative analysis, plaques harboring calcifications at baseline were found to have double the risk of developing intraplaque hemorrhage over the study period compared to non-calcified plaques. Such findings compel a re-evaluation of calcification’s protective role and suggest that certain spatial and compositional interactions within plaques may catalyze vulnerability rather than stability.

Further dissecting the temporal progression of plaque morphology, the researchers noted a marked increase in plaque complexity over the six-year interval. Initial plaques, often composed of a single predominant component, evolved into multifaceted lesions exhibiting combinations of calcification, hemorrhage, and lipid-rich necrotic cores. This morphological diversification was more pronounced in male participants, hinting at possible sex-related biological differences in plaque pathophysiology. Such complexity is clinically significant, as multicomponent plaques are widely associated with increased propensity for rupture and adverse cerebrovascular outcomes.

To extend their findings beyond the temporal confines of their cohort data, the investigators employed computational simulations to project plaque evolution trajectories over three decades. These simulations suggested that more than half of participants presenting with mono-component plaques at early midlife would eventually develop highly complex, multicomponent plaques by age 70. Such predictive modeling reinforces the imperative for early identification and surveillance of carotid atherosclerosis, even when clinical symptoms are absent.

The mechanistic underpinnings of how calcification influences intraplaque hemorrhage remain an active area of inquiry. Hypotheses posit that calcified nodules may incur mechanical stress on the fragile neovessels within plaques, promoting rupture and bleeding internally. Furthermore, calcification might disrupt the biomechanical integrity of the fibrous cap, rendering plaques more susceptible to fissuring under hemodynamic forces. Understanding these interactions at the microenvironment level is essential for developing targeted therapies aimed at stabilizing vulnerable plaques.

From a clinical standpoint, this research underscores the critical importance of vigilant monitoring of carotid plaque composition through serial imaging. Traditional risk assessment models focusing solely on plaque size or degree of stenosis may be insufficient, as compositional evolution, particularly the emergence of intraplaque hemorrhage, seems paramount in dictating stroke risk. Consequently, integrating advanced MRI techniques into routine evaluations could enhance personalized risk stratification and facilitate timely intervention.

Moreover, the data advocate for aggressive management of modifiable cardiovascular risk factors, even in asymptomatic individuals exhibiting early carotid plaque development. Factors such as hypertension, hyperlipidemia, smoking, and diabetes mellitus are well-established contributors to atherosclerotic progression and may influence plaque composition dynamics. Early and sustained control of these parameters could potentially mitigate the transition from stable to high-risk plaque phenotypes.

Dr. Bos and colleagues emphasize that their findings do not suggest immediate alarm but rather a call for heightened clinical awareness. Given the silent yet insidious evolution of carotid plaques, asymptomatic patients often remain unaware of their heightened cerebrovascular risks until catastrophic events occur. Incorporating periodic MRI evaluations and comprehensive cardiovascular risk management strategies may ultimately reduce the incidence of stroke attributed to plaque rupture.

The study also opens avenues for further research exploring how different plaque constituents interact over time and contribute to lesion destabilization. For example, elucidating the biochemical signals and cellular pathways triggered by calcification-related mechanical stresses may reveal novel pharmacological targets. Additionally, prospective trials assessing the impact of therapeutic interventions on plaque composition evolution and clinical outcomes are warranted.

In sum, this landmark investigation redefines our understanding of carotid atherosclerosis progression and accentuates the complexity underlying plaque stability. The revelation that calcified plaques harbor a substantive risk for intraplaque hemorrhage and subsequent rupture compels a revision of clinical paradigms and highlights the transformative role of serial high-resolution MRI imaging in vascular medicine. As cerebrovascular disease remains a leading cause of morbidity and mortality worldwide, such insights are timely and critical for advancing stroke prevention strategies.

Subject of Research: People

Article Title: Evolution of Subclinical Carotid Atherosclerotic Plaque Composition Using Serial MRI in the Rotterdam Study

News Publication Date: 3-Jun-2025

Web References:
https://pubs.rsna.org/journal/radiology
https://www.rsna.org/
http://www.radiologyinfo.org

Image Credits: Radiological Society of North America (RSNA)

Keywords:
Carotid artery, Circulatory system, Anatomy, Health and medicine, Diseases and disorders